Evidence map›Paper›PMID 17703184›Full record

Trial reportJournal of perinatology : official journal of the California Perinatal Association2007

A randomized controlled trial of synchronized nasal intermittent positive pressure ventilation in RDS.

V Bhandari, R G Gavino, J H Nedrelow, P Pallela, A Salvador, R A Ehrenkranz, N L Brodsky

Registry-linked trialAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Journal of perinatology : official journal of the California Perinatal Association, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00821119 (A Randomized Controlled Trial of Nasal Intermittent Positive Pressure Ventilation Versus Nasal Continuous Positive Pressure as a Primary Mode for Respiratory Distress Syndrome in Preterm Infants), which is not on this map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00821119 nacompletednot on this map

A Randomized Controlled Trial of Nasal Intermittent Positive Pressure Ventilation Versus Nasal Continuous Positive Pressure as a Primary Mode for Respiratory Distress Syndrome in Preterm Infants

TypeinterventionalSponsorInstituto Materno Infantil Prof. Fernando FigueiraRan2007 to 2009Enrolled200ConditionsPrematurity, Respiratory Distress SyndromeArmsnasal intermittent positive pressure ventilation
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Bubble NIPPV: Guidelines for Use.Children (Basel, Switzerland) · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Advances in respiratory support for high risk newborn infants.Maternal health, neonatology and perinatology · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

V BhandariDepartment of Pediatrics, Albert Einstein Medical Center, Philadelphia, PA, USA. vineet.bhandari@yale.edu
R G Gavino
J H Nedrelow
P Pallela
A Salvador
R A Ehrenkranz
N L Brodsky
Einstein Medical Center Philadelphia · USYale University · US

Funding

NICHD NIH HHS T32 HD-07049
6 · The paper itself

Abstract

objectiveComparison of outcomes of infants with respiratory distress syndrome (RDS), post-surfactant, extubated to synchronized nasal intermittent positive pressure ventilation (SNIPPV) or continued on conventional ventilation (CV). STUDY

designProspective post-surfactant randomized controlled trial of primary mode SNIPPV compared with CV in infants (born from July 2000 to March 2005) with birth weights (BW) of 600 to 1250 g. Primary mode SNIPPV was defined as its use in the acute phase of RDS, following the administration of the first dose of surfactant.

resultThere were no significant differences in the maternal demographics, antenatal steroid use, mode of delivery, BW, gestational age, gender or Apgar at 5 min between infants continued on CV (n=21) and those extubated to primary mode SNIPPV (n=20). Significantly, more babies in the CV group had the primary outcome of bronchopulmonary dysplasia (BPD)/death, compared to the SNIPPV group (52 versus 20%, P=0.03). There was no difference in the incidence of other common neonatal morbidities. There were no differences in the Mental or Psychomotor Developmental Index scores on follow-up between the two groups.

conclusionInfants of BW 600 to 1250 g with RDS receiving surfactant with early extubation to SNIPPV had a significantly lower incidence of BPD/death. Primary mode SNIPPV is a feasible method of ventilation in small premature infants.

Indexed as

Combined Modality TherapyContinuous Positive Airway PressureFeasibility StudiesFemaleHospital MortalityHumansInfant, NewbornInfant, Very Low Birth WeightIntermittent Positive-Pressure VentilationMaleProspective StudiesPulmonary SurfactantsRespiratory Distress Syndrome, NewbornSurvival AnalysisVentilator WeaningPulmonary Surfactants

Identifiers

PMID17703184
OpenAlexW2141187456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.